Back to search

National and Kapodistrian University of Athens

Μελέτη της ρύθμισης της γονιδιακής έκφρασης των καλλικρεϊνών και της L-DOPA αποκαρβοξυλάσης, μέσω των μορίων microRNA, στον καρκίνο του μαστού: αξιολόγηση της διαφοροδιαγνωστικής, προβλεπτικής και προγνωστικής αξίας

Abstract

dc:description

Aim of the study: The expression analysis and clinical evaluation of KLK8 and DDC, as well as the microRNA molecules which target the genes of interest, miR-224 and miR-145. Materials and Methods: Breast tissues (cancerous and non-cancerous, N=250) were homogenized and total RNA was extracted, polyadenylated (for miRNA analyses) and reverse transcribed into cDNA. Using different miRNA target prediction algorithms, we selected for further analysis two miRNAs, miR-224 and miR-145. Thereafter, KLK8, DDC and miR-224 and miR-145 expression levels, were quantified using Real-Time PCR. The clinical evaluation of the prognostic and the differential diagnostic potential of the biomolecules under study, was accomplished by using extensive biostatistical analyses. Results – Conclusion: Multivariate analysis showed that KLK8 expression is a strong and independent predictor of adverse DFS in breast cancer (HR=4.54, P=0.004). DDC mRNA levels were increased in a statistically significant degree in Ki67 positive (P=0.023) and high histological grade breast tumors (P=0.020). DDC mRNA expression was identified as strong independent indicator of unfavorable outcome with regard to DFS, for breast cancer patients (HR=3.82, P=0.033). In the case of miR-224, we observed that high-levels of miR-224 expression, is also a significant unfavorable prognostic marker independent of other clinicopathological factors (HR=4.86, P=0.014). miR-145, was found to be lower in high histological grade breast tumors (P<0.001) and in Ki67 positive ones (P<0.001). It is worth mentioning here, that DDC expression profile was the exact opposite in breast tumors with these clinicopathological features. In conclusion, the biomolecules under study, represent promising molecular indicators that could aid in the differential diagnosis and provide accurate prognostic information for breast cancer patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Michaelidou, Kleita
  • Μιχαηλίδου, Κλείτα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36555

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Michaelidou, Kleita; Μιχαηλίδου, Κλείτα. Μελέτη της ρύθμισης της γονιδιακής έκφρασης των καλλικρεϊνών και της L-DOPA αποκαρβοξυλάσης, μέσω των μορίων microRNA, στον καρκίνο του μαστού: αξιολόγηση της διαφοροδιαγνωστικής, προβλεπτικής και προγνωστικής αξίας. National and Kapodistrian University of Athens, 2015. http://hdl.handle.net/10442/hedi/36555